세계의 입자선 치료 시장 규모 : 유형, 제품 및 서비스, 암 유형, 지역별 예측(2022-2028년)

Global Particle Therapy Market is valued at approximately USD 625.69 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2028. Particle therapy is a type of external beam radiotherapy that uses beams of energetic protons, neutrons, or any other heavy positive ions to cure cancer. Factors such as increasing incidences of cancer, rising adoption of particle therapy in clinical trials, the advent of novel technologies, and a growing number of particle therapy centers worldwide are the primarily attributing to the growth of the market. For instance, according to the National Cancer Institute, in 2018, the total number of cancer patients is accounted for 18.1 million cases and the figure is projected to rise and likely to reach 29.5 million cases. Consequentially, the rising prevalence of cancer is fueling the demand for Particle Therapy, which, in turn, accelerates the market growth across the globe. However, the growing risk of exposure to radiation and infrastructural challenges in healthcare facilities impede the growth of the market over the forecast period of 2022-2028. Also, increasing demand for particle therapy in emerging markets and growing healthcare expenditure are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Particle Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the presence of the huge patient pool and growing initiatives to promote the adoption of advanced particle therapy technologies. Whereas, North America is anticipated to exhibit a substantial growth rate over the forecast period 2022-2028. Factors such as the rising preference for particle therapy owing to the various benefits offered compared to other procedures, as well as, the availability of favorable reimbursement scenarios, would create lucrative growth prospects for the Particle Therapy Market across the North American region.

Major market players included in this report are:

Varian Medical Systems, Inc.

Hitachi, Ltd.

Sumitomo Heavy Industries, Ltd.

Danfysik A/S

Hitachi, Ltd

Ion Beam Applications Sa (IBA)

Mevion Medical Systems, Inc.

Optivus Proton Therapy, Inc.

ProTom International, Inc.

Provision Healthcare, LLC

Sumitomo Heavy Industries, Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Proton Therapy

Heavy Ion Therapy

By Product & Service:

Products

Services

By Cancer Type:

Pediatric Cancer

Prostate Cancer

Lung Cancer

Breast Cancer

Head and Neck Cancer

Other Cancers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Particle Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Particle Therapy Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Particle Therapy Market, by Type, 2020-2028 (USD Million)
  • 1.2.3. Particle Therapy Market, by Product & Service, 2020-2028 (USD Million)
  • 1.2.4. Particle Therapy Market, by Cancer Type, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Particle Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Particle Therapy Market Dynamics

• 3.1. Particle Therapy Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidences of cancer
    • 3.1.1.2. Rising adoption of particle therapy in clinical trials
  • 3.1.2. Market Challenges
    • 3.1.2.1. Growing risk for the exposure to radiation
    • 3.1.2.2. Infrastructural challenges in healthcare facilities
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing demand for particle therapy in emerging markets
    • 3.1.3.2. Growing healthcare expenditure

Chapter 4. Global Particle Therapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Particle Therapy Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Particle Therapy Market by Type, Performance - Potential Analysis
• 6.3. Global Particle Therapy Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
• 6.4. Particle Therapy Market, Sub Segment Analysis
  • 6.4.1. Proton Therapy
  • 6.4.2. Heavy Ion Therapy

Chapter 7. Global Particle Therapy Market, by Product & Service

• 7.1. Market Snapshot
• 7.2. Global Particle Therapy Market by Product & Service, Performance - Potential Analysis
• 7.3. Global Particle Therapy Market Estimates & Forecasts by Product & Service, 2018-2028 (USD Million)
• 7.4. Particle Therapy Market, Sub Segment Analysis
  • 7.4.1. Products
  • 7.4.2. Services

Chapter 8. Global Particle Therapy Market, by Cancer Type

• 8.1. Market Snapshot
• 8.2. Global Particle Therapy Market by Cancer Type, Performance - Potential Analysis
• 8.3. Global Particle Therapy Market Estimates & Forecasts by Cancer Type, 2018-2028 (USD Million)
• 8.4. Particle Therapy Market, Sub Segment Analysis
  • 8.4.1. Pediatric Cancer
  • 8.4.2. Prostate Cancer
  • 8.4.3. Lung Cancer
  • 8.4.4. Breast Cancer
  • 8.4.5. Head and Neck Cancer
  • 8.4.6. Other Cancers

Chapter 9. Global Particle Therapy Market, Regional Analysis

• 9.1. Particle Therapy Market, Regional Market Snapshot
• 9.2. North America Particle Therapy Market
  • 9.2.1. U.S. Particle Therapy Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Product & Service breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Particle Therapy Market
• 9.3. Europe Particle Therapy Market Snapshot
  • 9.3.1. U.K. Particle Therapy Market
  • 9.3.2. Germany Particle Therapy Market
  • 9.3.3. France Particle Therapy Market
  • 9.3.4. Spain Particle Therapy Market
  • 9.3.5. Italy Particle Therapy Market
  • 9.3.6. Rest of Europe Particle Therapy Market
• 9.4. Asia-Pacific Particle Therapy Market Snapshot
  • 9.4.1. China Particle Therapy Market
  • 9.4.2. India Particle Therapy Market
  • 9.4.3. Japan Particle Therapy Market
  • 9.4.4. Australia Particle Therapy Market
  • 9.4.5. South Korea Particle Therapy Market
  • 9.4.6. Rest of Asia Pacific Particle Therapy Market
• 9.5. Latin America Particle Therapy Market Snapshot
  • 9.5.1. Brazil Particle Therapy Market
  • 9.5.2. Mexico Particle Therapy Market
• 9.6. Rest of The World Particle Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Varian Medical Systems, Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Hitachi, Ltd.
  • 10.2.3. Sumitomo Heavy Industries, Ltd.
  • 10.2.4. Danfysik A/S
  • 10.2.5. Hitachi, Ltd
  • 10.2.6. Ion Beam Applications Sa (IBA)
  • 10.2.7. Mevion Medical Systems, Inc.
  • 10.2.8. Optivus Proton Therapy, Inc.
  • 10.2.9. ProTom International, Inc.
  • 10.2.10. Provision Healthcare, LLC
  • 10.2.11. Sumitomo Heavy Industries, Ltd.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption